Advertisements

Piridoxina

Quick links to important sections

Piridoxina

Advertisements

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Piridoxina

Piridoxina is the international nonproprietary name (INN) for Vitamin B6, an essential, water-soluble nutrient belonging to the B-complex family. It is vital for numerous biological processes, primarily acting as a coenzyme in metabolism and supporting nerve function.

Property Description
Active Ingredient Pyridoxine (Vitamin B6)
Form Water-soluble vitamin (commonly as hydrochloride salt)
Pharmacological Class Vitamin / Nutritional Supplement
Common Use Prevention and treatment of Vitamin B6 deficiency; co-treatment for certain neuropathies.
OTC/Rx Status Primarily Over-the-Counter (OTC); high-dose or injectable forms may be Prescription (Rx).

Overview and Function

Piridoxina is a critical substance because it is converted in the body into its active form, pyridoxal 5-phosphate (PLP). This coenzyme is responsible for assisting over 100 enzyme reactions, predominantly involved in the processing of proteins, carbohydrates, and fats. This foundational role in metabolism ensures energy production and supports various systemic functions.

Beyond metabolism, Piridoxina holds a key function in neurological and blood health. The active form is necessary for the biosynthesis of several key neurotransmitters, such as serotonin and norepinephrine, which are essential for mood regulation and normal brain function. Furthermore, Vitamin B6 is essential for the production of hemoglobin, the protein responsible for carrying oxygen in red blood cells. This process ensures efficient oxygen transport throughout the body.

Its clinical recognition is broad, often being used to prevent and treat deficiencies, but also playing a specific role in certain clinical contexts, such as being a standard component in prescription combinations used to manage nausea and vomiting associated with pregnancy.

Regulatory References

  1. MedlinePlus Information
  2. U.S. National Library of Medicine
Advertisements

What side effects are possible with Piridoxina?

Possible side effects and safety information

The safety profile of Piridoxina (Vitamin B6) is defined by regulatory bodies largely based on the dosage and duration of exposure, differentiating between nutritional intake and long-term, high-dose use.


Adverse Reaction Scope

The most clinically significant adverse effect is severe peripheral neuropathy, which is a dose- and duration-dependent toxicity associated with the long-term administration of large doses that significantly exceed typical recommended intake. This condition, characterized by sensory disturbances, is the primary safety constraint noted in regulatory documents.

Commonly reported non-specific reactions include nausea, headache, and somnolence (drowsiness). However, for use at typical therapeutic doses, precise frequency classifications are often listed as 'Not Known' based on post-marketing reports.

Adverse effects are formally classified by System-Organ Class, with a primary focus on Nervous System Disorders and Immune System Disorders (e.g., hypersensitivity/allergic reactions).


Population and Restriction Notes

Official labeling contains specific notes regarding special populations. For pregnancy and lactation, use at therapeutic doses is generally considered to pose minimal risk. A specific safety restriction noted in prescribing information is that high-dose Pyridoxine may reduce the efficacy of levodopa (a medication for Parkinson's disease) when administered without a dopa decarboxylase inhibitor.

This safety profile is structured to emphasize that the risk of serious adverse reactions, particularly nerve damage, is related to chronic, high cumulative intake.

Advertisements

Overdose and Emergency Response

The official regulatory profile for Piridoxina ( Vitamin B6) overdose centers on peripheral sensory neurotoxicity, which is the primary documented consequence of chronic, high-dose exposure. The manifestation of overdose commonly includes paresthesia (tingling, numbness), ataxia (loss of coordination), and muscle weakness. Gastrointestinal disorders such as nausea may also be documented.

Immediate medical attention must be sought if these neurological symptoms occur, as continued intake can lead to the progression of nerve damage, including severe sensory loss and the risk of permanent nerve damage. Patients are instructed in regulatory documents to immediately stop taking all Piridoxina supplements upon recognizing these signs. For acute, massive ingestions, emergency services should be contacted for life-threatening symptoms such as seizure, collapse, or trouble breathing.

The official prescribing information notes that no specific antidote is known for Piridoxina toxicity; therefore, management is based on supportive and symptomatic treatment, alongside cessation of the source. Population-specific risks include the documented potential for pyridoxine withdrawal seizures in neonates exposed to high doses prenatally.

Advertisements

Therapeutic Uses of Piridoxina

What Piridoxina Treats: Main Uses and Benefits


Piridoxina (Vitamin B6) is commonly used to address fundamental nutritional needs and specific symptomatic challenges, focusing on supportive care across several distinct domains. It is considered relevant in conditions characterized by systemic imbalance arising from a Vitamin B6 deficiency.

It is applied across domains where additional symptomatic support is needed, including the management of nausea and vomiting associated with pregnancy, and is relevant for easing symptomatic discomfort. Furthermore, it is commonly used to help with the management of symptoms related to neurological strain (e.g., plays a role in managing the risk of nerve damage) or is applied in addressing symptomatic episodes like B6-responsive seizures. This therapeutic use generally supports patients during episodes of heightened discomfort when symptoms are more noticeable.

“Piridoxina helps address symptom clusters like specific forms of anemia and mucocutaneous issues (e.g., itchy rashes or a swollen tongue), supporting general well-being during symptomatic phases.”

Quick Fact: Relief for Pregnancy Nausea

Piridoxina is considered relevant in the initial management strategy for mild to moderate nausea and vomiting during pregnancy, and is generally applied when supportive symptom management is appropriate to contribute to improved comfort during periods of heightened symptoms.

Advertisements

Eligibility and Restrictions for Use

Who can and cannot use Pyridoxine (Piridoxina) — Official Regulatory Information

The eligibility profile for Pyridoxine (Vitamin B6) is defined by a primary exclusion and several conditional use requirements, based on official government regulatory documents.

Eligibility Scope

Category Eligibility Status Conditions for Use/Exclusion
Contraindicated Must Not Use Individuals with known hypersensitivity to Pyridoxine or any component of the specific formulation.
Pregnancy/Lactation Conditional Use Therapeutic doses are generally allowed; high doses are cautioned against as they may potentially interfere with lactation or affect the infant.
Children/Pediatric Restricted Use Specific high-strength formulations are not recommended due to the concentration exceeding age-appropriate limits.
Organ Impairment Conditional Use Patients with renal or hepatic impairment should use with caution, especially when Pyridoxine is co-administered with other potentially toxic medicines.

Eligibility-Related Restrictions

Regulatory documents emphasize that use is constrained by dosage level and formulation. While safe at nutritional or standard therapeutic doses for most adults, including older adults, eligibility shifts to restricted use for high doses due to the risk of peripheral neuropathy. The use of certain combination products is also restricted in patients with conditions like narrow angle glaucoma or stenosing peptic ulcer due to other ingredients.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Piridoxina (Vitamin B6) interactions are officially documented in regulatory labeling, primarily defining how the plasma concentration and status of the vitamin, or that of a co-administered medicine, are altered.

Interaction-Related Restrictions and Constraints

Classification Interacting Substance Official Constraint / Outcome
Functional Prohibition Levodopa (without DOPA decarboxylase inhibitor) Co-administration is prohibited as Piridoxina severely reduces Levodopa's effectiveness by increasing its peripheral metabolism.
Exposure Reduction Phenytoin, Phenobarbital Piridoxina is documented to cause a reduction in the plasma concentrations of these anticonvulsant medicines.
Increased Requirement Isoniazid (INH), Hydralazine, Penicillamine Concurrent use of these medicines is officially stated to increase the required amount of Piridoxina due to accelerated clearance or metabolic interference.
Substance Interaction Oral Contraceptives (estrogen-containing) Officially documented to decrease Piridoxina plasma concentrations, increasing the need for the vitamin.
Substance Interaction Alcohol (chronic high-volume use) Documented to increase the metabolic breakdown and urinary excretion of Piridoxina, leading to reduced status.

Connection to the Overall Interaction Profile

The regulatory interaction profile is defined by pharmacokinetic alterations, where specific agents increase the vitamin's metabolic clearance, and Piridoxina may reduce the levels of certain co-administered drugs. The most significant constraint is the functional prohibition against combining Piridoxina with uninhibited Levodopa due to its impact on the antiparkinsonian agent's efficacy, a constraint that requires full avoidance of the combination.

Advertisements

Mechanism of Action

The mechanism of action for Piridoxina (Pyridoxine) involves its role as the precursor to the essential coenzyme, Pyridoxal 5-Phosphate ( PLP). Its influence is not mediated by receptor binding, but by integrating into and activating key metabolic enzymes across the body.

PLP Coenzyme Action in Neurotransmitter Synthesis

This domain focuses on PLP's cofactorial requirement for enzymes like Glutamic Acid Decarboxylase ( GAD). By promoting the synthesis of critical inhibitory neurotransmitters, such as gamma-Aminobutyric acid ( GABA), the mechanism directly affects neuronal excitability modulation within the central nervous system ( CNS).

Regulation of Systemic Metabolism and Heme Production

PLP is essential for over 100 enzymes, including those governing amino acid interconversion and the rate-limiting enzyme in heme synthesis ( Aminolevulinic Acid Synthase). This systemic role affects oxygen carrying capacity and contributes to the regulation of fundamental metabolic processes necessary for cellular structure maintenance.

Modulation of Cellular Energy Mobilization

This mechanism involves PLP's requirement for the function of Glycogen Phosphorylase, the enzyme responsible for initiating the breakdown of stored glucose (glycogen). By supporting this enzyme, PLP contributes to the mobilization of glucose from stored reserves for tissue energy metabolism.

Advertisements

Dosage and Administration Information

Official Administration Guidelines for Pyridoxine

Instructions for the use of Pyridoxine (Vitamin B6) are defined by established guidelines, specifying the administration routes, dosage amounts, and procedural requirements.

Approved Administration Scope

Feature Standard Administration Instructions
Route of Administration Oral (Tablet, Solution, Powder), Intramuscular (IM) Injection, Intravenous (IV) Injection, Subcutaneous (Sub-Q) Injection.
Dosing Frequency Typically Once Daily for prophylaxis/maintenance; Daily in Divided Doses for deficiency treatment; Three Times Daily for established neuropathy; or Interval-Based for acute conditions (e.g., every 30 minutes in poisoning).
Preparation Oral extended-release tablets must be swallowed whole and not crushed, broken, or chewed. Oral powder must be mixed with liquid/food and ingested immediately. Parenteral solutions must minimize light exposure and may require dilution.
Timing (Meals) Oral forms can often be taken without strict timing relative to meals, though some combination products specify use on an empty stomach.

Population and Procedural Rules

Official instructions differentiate dosing by age, with specific daily amounts provided for pediatric populations for deficiency prevention, while dosages for geriatric patients are typically similar to those for adults. The parenteral route is reserved for patients where oral absorption is impaired or in acute, critical situations (e.g., seizures or poisoning). If a dose is missed, guidelines instruct patients to skip the missed dose and resume the regular schedule, and to never double the dose to compensate.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Piridoxina

Evidence for Correcting Vitamin B6 Deficiency and Dependency Syndromes

Piridoxina (Vitamin B6) was studied for its role in addressing conditions arising from low levels of the vitamin in the body. The research base includes historical regulatory review documents and numerous case reports detailing patient experiences. Small Randomized Controlled Trials (RCTs) were evaluated in infants and children presenting with specific, rare B6-responsive seizures.

The outcomes research examined were objective measures like the shift in the levels of plasma pyridoxal 5-phosphate (PLP). Studies reported observed changes in PLP levels after administration. What remains uncertain is the lack of large, modern RCTs for simple deficiency correction, where evidence relies on established foundational science.


Evidence for Nausea and Vomiting Associated with Pregnancy

Piridoxina was studied for the supportive evaluation of episodic or acute changes related to mild to moderate nausea and vomiting during pregnancy (NVP). The research is supported by multiple Randomized Controlled Trials (RCTs), many of which were double-blind and placebo-controlled.

The studies monitored outcomes related to perceived discomfort using validated symptom severity scores. Findings indicate patterns related to symptomatic relief, particularly when Piridoxina was observed in some studies as part of a combination product with another agent. The evidence quality varies across studies when Piridoxina is evaluated in isolation, with results often reporting a marginal difference in outcome scores compared to the differences observed with combination products.


Evidence for Neurological Support and Preventing Drug-Induced Neuropathy

Piridoxina was evaluated in studies exploring nerve-related study outcomes, particularly the prevention of nerve damage caused by medications like isoniazid (INH). The research examined outcomes related to preventing the incidence of neuropathy development during INH treatment. The data show patterns related to a lower incidence of neuropathy in patients where Piridoxina was co-administered. This evidence informed the development of standard care practices.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Piridoxina (FAQ)


Q: Why would a doctor prescribe Piridoxina?

A: Piridoxina, or Vitamin B6, is prescribed primarily to address a deficiency caused by a poor diet or for deficiencies associated with certain medications. Official prescribing information also indicates its use for specific inborn errors of metabolism, such as B6-dependent convulsions.


Q: Does taking Piridoxina make you feel tired?

A: Official reports on the safety profile of Piridoxina note that sleepiness (or somnolence) is an adverse effect that has been reported by some users. Concerns about unusual or severe sleepiness should be discussed with a healthcare provider.


Q: Can Piridoxina be taken on an empty stomach?

A: Official administration instructions for some Piridoxina products, such as certain extended-release combination forms, state that they may be taken on an empty stomach. This typically means taking the medicine at least one hour before or two hours after eating a meal.


Q: What are the early warning signs of Piridoxina toxicity?

A: The primary safety concern with high doses of Piridoxina is peripheral neuropathy, which is nerve damage. Symptoms reported in connection with high-dose toxicity include numbness and tingling (paresthesia), particularly in the hands and feet, or difficulty with walking and coordination.


Q: Is it possible to take too much Piridoxina?

A: Yes, taking Piridoxina consistently at high levels may pose a safety risk over time. Long-term intake of high doses, such as those exceeding 100 mg per day for adults, is specifically associated with the risk of peripheral neuropathy, which is damage to the nerves outside the brain and spinal cord.


Q: What is the maximum recommended daily intake of Piridoxina?

A: The established Tolerable Upper Intake Level (UL) for Piridoxina (Vitamin B6) in adults (ages 19 and older) is set at 100 mg per day. This level represents the maximum daily intake that is generally considered unlikely to cause adverse health effects in the majority of individuals.


Q: What groups of people are most likely to need Piridoxina supplementation?

A: Official health guidelines and regulatory documents highlight that certain groups may have a higher requirement or be at risk of lower levels. These include individuals with impaired kidney function (such as those on dialysis), those with alcohol dependence, or people with certain autoimmune disorders.


Q: Why do people with kidney disease sometimes need Piridoxina supplements?

A: Regulatory health documents note that people who have impaired kidney function, particularly those undergoing dialysis, often have a harder time maintaining adequate Piridoxina levels. For this reason, a healthcare provider may recommend supplementation for individuals with kidney disease to maintain appropriate levels.


Q: Can Piridoxina help with certain types of anemia?

A: Yes, official product indications include the management of specific types of anemia. These conditions are Vitamin B6 responsive anemia (related to metabolism errors) and idiopathic sideroblastic anemia.


Q: Do older adults process Piridoxina differently than younger people?

A: Official health resources indicate that the Recommended Dietary Allowance (RDA) for Piridoxina is slightly higher for adults aged 51 years and older compared to younger adults. This may reflect a difference in recommended nutritional intake for maintaining adequate levels as people age.


Q: Is Piridoxina available over-the-counter or only by prescription?

A: Piridoxina is primarily available as an Over-the-Counter (OTC) vitamin supplement. However, certain high-strength doses or injectable forms may be classified as Prescription (Rx) medicine.


Q: Can Piridoxina be taken with other B vitamins, like B12 or Folic Acid?

A: Yes, regulatory documents show that Piridoxina is very commonly available in multivitamin/mineral supplements and products that combine it with other B-complex vitamins, such as B12 and Folic Acid.


Q: Is the Piridoxina from a supplement absorbed better than from food?

A: The body generally absorbs Piridoxina well. However, official information shows that consuming food alongside a supplement can reduce its bioavailability (how much of it reaches the bloodstream) compared to taking it on an empty stomach.


Q: How is Piridoxina different from pyridoxal-5-phosphate (P5P)?

A: The difference is related to activity: Piridoxina is the initial form, or precursor, of the vitamin. The body must convert Piridoxina into its active coenzyme form, which is called pyridoxal-5-phosphate (P5P), to perform its essential functions.


Q: Does Piridoxina help maintain healthy immune function?

A: Yes, official health fact sheets and regulatory documents confirm that Piridoxina is necessary for supporting healthy immune function. Deficiency in the vitamin can sometimes be associated with a weakened immune response.


Q: Can children take Piridoxina safely, and for what conditions?

A: Piridoxina is used to prevent vitamin deficiency in children and is specifically indicated for treating B6-dependent convulsions, a rare seizure disorder in infants. Official documents caution that specific high-strength formulations are generally not recommended for routine pediatric use due to concentration and dosage considerations.


Q: How should I store my Piridoxina medication?

A: Official storage instructions require that Piridoxina be stored at Controlled Room Temperature (typically 20 C to 25 C), protected from both light and moisture. It should always be kept in its original container with the lid tightly closed.


Q: How long does Piridoxina stay in your system?

A: According to official pharmacokinetic data, the elimination half-life of Piridoxina is approximately 15 to 20 days. This is the amount of time it takes for half of the substance to be broken down and excreted in the urine as its primary metabolite.


Q: What are some natural sources of Piridoxina (Vitamin B6)?

A: Regulatory and health fact sheets list good natural sources of Piridoxina. These include poultry, fish, and organ meats, as well as plant sources like potatoes, starchy vegetables, and most fruits (excluding citrus fruits).


Q: Can vegetarians or vegans easily get enough Piridoxina from their diet?

A: Since rich sources of Piridoxina include meat and fish, vegetarians and vegans may need to ensure their intake from plant-based foods is sufficient, or consult with a professional. Key plant sources include starchy vegetables and fruits.


Q: Is it normal to feel a tingling sensation in the hands or feet when taking Piridoxina?

A: No, a persistent tingling sensation (paresthesia) is a symptom reported with peripheral neuropathy, which is the primary toxicity concern associated with high, long-term doses of Piridoxina. Such a symptom should be promptly discussed with a healthcare professional.


Q: What should I do if I notice an unusual skin rash after starting Piridoxina?

A: Official safety data classifies Immune System Disorders as a potential concern. A skin rash may be a sign of a hypersensitivity or allergic reaction. Any suspected allergic reaction should be reported to a healthcare professional.

Advertisements

How should Piridoxina be stored and disposed of?

Storage and Disposal Instructions for Piridoxina

The storage of Piridoxina (Vitamin B6) must comply with specific conditions defined in official regulatory labeling to ensure product stability and safety.

Official Storage Requirements

Condition Requirement
Temperature Store at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F); do not freeze.
Protection Must be protected from light and moisture and kept in a dry place.
Container Keep the medication in its original container, tightly closed.
Child Safety Store the product out of the reach and sight of children.

Disposal

Unused or expired Piridoxina must be disposed of in accordance with local requirements for pharmaceutical waste. Regulatory guidance advises against discarding the medicine in wastewater or general household trash; instead, utilize a medicine take-back program if available.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Piridoxina found in:

A-Z Index: